The following discussion and analysis provides information which management
believes is relevant to an assessment and understanding of Desktop Metal's
consolidated results of operations and financial condition. The discussion
should be read in conjunction with Desktop Metal's consolidated financial
statements and notes thereto included elsewhere in Annual Report on Form 10-K.
This discussion contains forward-looking statements and involves numerous risks
and uncertainties, including, but not limited to, those described under the
heading "Risk Factors". Actual results may differ materially from those
contained in any forward-looking statements.

Business Overview

Desktop Metal is pioneering a new generation of additive manufacturing
technologies focused on the production of end-use parts. We offer a portfolio of
integrated additive manufacturing solutions for engineers, designers and
manufacturers comprised of hardware, software, materials, and services. Our
solutions span use cases across the product life cycle, from product development
to mass production and aftermarket operations, and they address an array of
industries, including automotive, aerospace, healthcare, consumer products,
heavy industry, machine design and research and development.

Our growth strategy begins with a commitment to research and development. Since
our founding in 2015, we have invested significant resources in research and
development, including $43.1 million in 2020, towards building an extensive
portfolio of proprietary and differentiated technologies with a focus on making
additive manufacturing an easy-to-use, economic and scalable solution. Our
additive manufacturing products, which incorporate these technologies, offer
several key advantages over competitive additive manufacturing technologies and
provide our customers with several price points depending on their desired
features and applications. Our announced additive manufacturing platforms are as
follows:

Production System is an industrial manufacturing platform powered by our

proprietary SPJ technology, which is designed to achieve speeds up to 100 times

those of legacy Powder Bed Fusion (PBF) additive manufacturing technologies and

enable production quantities of up to millions of parts per year at part costs

• competitive with conventional mass production techniques. The Production System

platform consists of two printer models. The P-1, which began commercial

shipments in the fourth quarter of 2020, is a small form factor solution for

process development and serial production applications. The P-50, which is

scheduled to begin commercial shipments in 2021, is a large form factor mass

production solution for end-use parts.

Shop System is an affordable, turnkey binder jetting platform designed to bring

metal 3D printing to machine and job shops, leveraging build rates up to 10

• times those of legacy PBF additive manufacturing technologies in combination

with our proprietary sintering technology to enable serial production of dense

metal parts with exceptional surface finish and rich feature detail. Shop

System began commercial shipments in the fourth quarter of 2020.

Studio System is designed for office-friendly metal 3D printing and leverages

our proprietary BMD technology to minimize requirements for special facilities

as compared to legacy PBF additive manufacturing technologies and simplify the

• production of low volumes of complex, high quality metal parts in-house. Studio

System has been shipping in volume since the fourth quarter of 2018, and in

February 2020, we announced a second-generation platform, Studio System 2,

which further streamlines the BMD process.

Fiber is a desktop 3D printer that incorporates our proprietary Micro AFP

technology and is designed to produce high-resolution composite parts

• reinforced with aerospace- and industrial-grade continuous fiber tape,

unlocking superior part strength with high-performance materials starting at an

affordable annual subscription price. Fiber began initial commercial shipments


   in the fourth quarter of 2020.


                                       44

  Table of Contents

Operating Results

For the year ended December 31, 2020, we recognized revenues of $16.5 million
and used cash in operating activities of $80.6 million, and we ended the year
with $595.4 million of cash, cash equivalents, and short-term investments. We
incurred a net loss of $90.4 million for the year ended December 31, 2020. In
December 2020, we completed the Business Combination, receiving $534.6 million
net cash proceeds, which we expect to support our operations and investments in
the near term.

Recent Developments

Trine Merger
On December 9, 2020, we consummated the Business Combination. Cash proceeds of
the Business Combination were funded through a combination of Trine's $305
million of cash held in trust, net of redemptions of $0.3 million, and an
aggregate of $275 million in gross proceeds to us from the sale of shares of our
Class A common stock in a private placement in connection with the Business
Combination, or the PIPE financing. Our cash on hand after giving effect to
these transactions will be used for general corporate purposes, including
advancement of our product development efforts. We also intend to use the
proceeds to acquire other companies or technologies in the additive
manufacturing industry.

The Business Combination was accounted for as a reverse recapitalization. Legacy
Desktop Metal has been determined to be the accounting acquirer based on the
following facts and circumstances:

• Legacy Desktop Metal's shareholders have majority of the voting power in

Desktop Metal;

• Legacy Desktop Metal has the ability to appoint a majority of the board of

directors of Desktop Metal;

• Legacy Desktop Metal's existing management comprises the management of Desktop

Metal;

• Legacy Desktop Metal comprises the ongoing operations of Desktop Metal;

• Legacy Desktop Metal is the larger entity based on historical revenues and

business operations; and

Desktop Metal assumed Legacy Desktop Metal's name.


Under this method of accounting, Trine is treated as the "acquired" company for
financial reporting purposes. Accordingly, for accounting purposes, the Business
Combination is treated as the equivalent of Legacy Desktop Metal issuing stock
for the net assets of Trine, accompanied by a recapitalization, and the
historical financial statements of Legacy Desktop Metal became the historical
financial statements of our company upon the closing of the Business
Combination.

EnvisionTEC Acquisition


On February 16, 2021, pursuant to the Purchase Agreement and Plan of Merger
dated January 14, 2021, we consummated the EnvisionTEC Acquisition. The Company
paid consideration of $143.8 million in cash and issued 5,036,142 Class A common
shares with a fair value of $159.8 million as of the close of business on the
acquisition date. In connection with the transaction, the Company also agreed to
grant restricted stock units totaling 475,848 shares of Class A common stock to
key EnvisionTEC employees.

COVID-19

In March 2020, the World Health Organization declared the outbreak of COVID-19 a
pandemic. It is not possible to accurately predict the full impact of the
COVID-19 pandemic on our business, financial condition and results of operations
due to the evolving nature of the COVID-19 pandemic and the extent of its impact
across industries and geographies and numerous other uncertainties. For example,
we face uncertainties about the duration and spread of the outbreak, additional
actions that may be taken by governmental entities, and the impact it may have
on the ability of us, our customers, our suppliers, our manufacturers and our
other business partners to conduct business. Governments in affected regions
have implemented, and may continue to implement, safety precautions which
include quarantines, travel restrictions, business closures, cancellations of
public gatherings and other measures as

                                       45

Table of Contents



they deem necessary. Many organizations and individuals, including our company
and employees, are taking additional steps to avoid or reduce infections,
including limiting travel and staying home from work. These measures are
disrupting normal business operations and have had significant negative impacts
on businesses and financial markets worldwide. We continue to monitor our
operations and government recommendations and have made modifications to our
normal operations because of the COVID-19 pandemic, including requiring most
non-engineering or operations-related team members to work remotely, utilizing
heightened cleaning and sanitization procedures, implementing new health and
safety protocols and reducing non-essential travel.

The COVID-19 pandemic has caused us to experience several adverse impacts,
including extended sales cycles to close new orders for our products, delays in
shipping and installing orders due to closed facilities and travel limitations
and delays in collecting accounts receivable. The rapid development and
uncertainty of the impacts of the COVID-19 pandemic precludes any prediction as
to the ultimate adverse impact of the COVID-19 pandemic on our business.
However, the COVID-19 pandemic, and the measures taken to contain it, present
material uncertainty and risk with respect to our performance and financial
results. In particular, businesses across an array of vertical markets are
temporarily reducing capital expenditure budgets globally as they seek to
preserve liquidity to ensure the longevity of their own operations, which in
turn may lead to reductions in purchases of our additive manufacturing
solutions. Further, office closures may prevent organizations from reaching
typical utilizations of our additive manufacturing solutions, resulting in
reductions in purchases of consumable materials. Additionally, the COVID-19
pandemic may contribute to facility closures at our third-party contract
manufacturers and key suppliers, causing delays and disruptions in product
manufacturing, which could affect our ability to ship products purchased by our
customers in a timely manner. Disruptions in the capital markets as a result of
the COVID-19 pandemic may also adversely affect our business if these impacts
continue for a prolonged period and we need additional liquidity.

In the short-term, we have taken, and will continue to take, actions to mitigate
the impact of the COVID-19 pandemic on our cash flow and results of operations
and financial condition. We are managing the variable portion of our cost
structure to better align with revenue, including external marketing spend,
which will be significantly reduced during this period of disruption. Similarly,
we have reduced discretionary research and development spending and plan to
continue to closely manage additional spend. Additionally, we have reduced
staffing across the organization by 30% across all departments. In the
long-term, we believe that the COVID-19 pandemic will encourage organizations to
reassess their supply chain structure and may accelerate their adoption of
solutions such as additive manufacturing, which could allow for greater
flexibility and a reduced reliance on overseas manufacturing.

Key Factors Affecting Operating Results



We believe that our performance and future success depend on many factors that
present significant opportunities for us but also pose risks and challenges,
including those discussed below and in "Risk Factors" section of this Annual
Report on Form 10-K.

Commercial Launch of Products


Several of our products began commercial shipments in late 2020, with more in
the late stages of development and scheduled to begin commercial shipments in
2021. Prior to commercialization, we must complete final testing and
manufacturing ramp-up of these products at our third-party contract
manufacturers. Any delays in successful completion of these steps may impact our
ability to generate revenue from these products.

Adoption of our Additive Manufacturing Solutions


We believe the world is at an inflection point in the adoption of additive
manufacturing solutions and that we are well-positioned to take advantage of
this opportunity across an array of industries due to our proprietary
technologies and global distribution capabilities. We expect that our results of
operations, including revenue and gross margins, will fluctuate for the
foreseeable future as businesses continue to shift away from conventional
manufacturing processes towards additive manufacturing for end-use parts. Our
turnkey and volume production solutions are designed to empower businesses to
realize the full benefits of additive manufacturing at-scale, including
geometric and design flexibility, mass customization and supply chain
engineering, among others. The degree to which potential and current customers
recognize these benefits and invest in our solutions will affect our financial
results.

                                       46

  Table of Contents

Pricing, Product Cost and Margins


While most of our revenue to date has been generated by sales of our Studio
System, we began commercial shipments of several previously announced products
in late 2020, which offer customers a range of additive manufacturing solutions
spanning multiple price points, materials, throughput levels, operating
environments and technologies to enable them to find the solution that achieves
their specific goals. We also expect to commercialize additional previously
announced products over the course of 2021. Pricing for these products may vary
by region due to market-specific supply and demand dynamics and product
lifecycles, and sales of certain products have, or are expected to have, higher
gross margins than others. As a result, our financial performance depends, in
part, on the mix of products we sell during a given period. In addition, we are
subject to price competition, and our ability to compete in key markets will
depend on the success of our investments in new technologies and cost
improvements as well as our ability to efficiently and reliability introduce
cost-effective additive manufacturing solutions for our customers.

Continued Investment and Innovation



We believe that we are a leader in mass production and turnkey additive
manufacturing solutions, offering breakthrough technologies that enable high
throughput and ease-of-use through our broad product portfolio. Our performance
is significantly dependent on the investment we make in our research and
development efforts and on our ability to be at the forefront of the additive
manufacturing industry. It is essential that we continually identify and respond
to rapidly evolving customer requirements, develop and introduce innovative new
products, enhance existing products and generate customer demand for our
solutions. We believe that investment in our additive manufacturing solutions
will contribute to long-term revenue growth, but it may adversely affect our
near-term profitability.

Components of Results of Operations

Revenue



The majority of our revenue results from the sales of products, including our
additive manufacturing systems and embedded on-device software and related
consumables. Product revenue is recognized upon transfer of control to the
customer, which generally takes place at the point of shipment. We also generate
a portion of our revenue from software and support services. Software revenue is
recognized (i) in the case of on-device software, upon transfer of control to
the customer, which generally takes place upon shipment, and (ii) in the case of
cloud-based software, which is primarily sold through one-year annual contracts,
ratably over the term of the agreement. Revenue from support services for our
additive manufacturing systems is primarily generated through one-year annual
contracts and is recognized ratably over the term of the agreement.

We generate revenue and deliver products and services principally through sales
to resellers, who purchase and resell our products and also provide installation
and support services for our additive manufacturing solutions to end-users.
Occasionally and for certain products (and related consumables, software and
support services), we generate revenue from and deliver services to our
customers directly.

Cost of Revenue


Our cost of revenue consists of the cost of products and cost of services. Cost
of products includes the manufacturing cost of our additive manufacturing
systems and consumables, which primarily consists of amounts paid to our
third-party contract manufacturers and suppliers and personnel-related costs
directly associated with manufacturing operations. Cost of services includes
personnel-related costs directly associated with the provision of support
services to our customers, which include engineers dedicated to remote support
as well as, training, support and the associated travel costs. Our cost of
revenues also includes depreciation and amortization, cost of spare or
replacement parts, warranty costs, excess and obsolete inventory and shipping
costs, and an allocated portion of overhead costs. We expect cost of revenue to
increase in absolute dollars in future periods as we expect our revenues to

continue to grow.

                                       47

  Table of Contents

Gross Profit and Gross Margin

Our gross profit is calculated based on the difference between our revenues and cost of revenues. Gross margin is the percentage obtained by dividing gross profit by our revenue. Our gross profit and gross margin are, or may be, influenced by a number of factors, including:

? Market conditions that may impact our pricing;

? Product mix changes between established products and new products;

Growth in our installed customer base or changes in customer utilization of our

? additive manufacturing systems, which affects sales of our consumable materials

and may result in excess or obsolete inventories; and

? Our cost structure for manufacturing operations, including contract

manufacturers, relative to volume, and our product support obligations.

We expect our gross margins to fluctuate over time, depending on the factors described above.



Research and Development

Our research and development expenses represent costs incurred to support
activities that advance the development of innovative additive manufacturing
technologies, new product platforms and consumables, as well as activities that
enhance the capabilities of our existing product platforms. Our research and
development expenses consist primarily of employee-related personnel expenses,
prototypes, design expenses, consulting and contractor costs and an allocated
portion of overhead costs. We expect research and development costs will
increase on an absolute dollar basis over time as we continue to invest in
advancing our portfolio of additive manufacturing solutions.

Sales and Marketing



Sales and marketing expenses consist primarily of employee-related costs for
individuals working in our sales and marketing departments, third party
commissions, costs related to trade shows and events and an allocated portion of
overhead costs. We expect our sales and marketing costs will increase on an
absolute dollar basis as we expand our headcount, initiate new marketing
campaigns and launch new product platforms.

General and Administrative


General and administrative expenses consist primarily of personnel-related
expenses associated with our executive, finance, legal, information technology
and human resources functions, as well as professional fees for legal, audit,
accounting and other consulting services, and an allocated portion of overhead
costs. We expect our general and administrative expenses will increase on an
absolute dollar basis as a result of operating as a public company, including
expenses necessary to comply with the rules and regulations applicable to
companies listed on a national securities exchange and related to compliance and
reporting obligations pursuant to the rules and regulations of the SEC, as well
as increased expenses for general and director and officer insurance, investor
relations, and other administrative and professional services. In addition, we
expect to incur additional costs as we hire additional personnel and enhance our
infrastructure to support the anticipated growth of the business.

Interest Expense

Interest expense includes cash interest related to our term loan as well as amortization of deferred financing fees and costs.

Interest and Other Income, Net

Interest and other income, net includes interest earned on deposits and short-term investments and gains and losses on investments.



                                       48

  Table of Contents

Income Taxes

Our income tax provision consists of an estimate for U.S. federal and state and
foreign income taxes based on enacted rates, as adjusted for allowable credits,
deductions, uncertain tax positions, changes in deferred tax assets and
liabilities and changes in tax law. Due to cumulative losses, we maintain a
valuation allowance against our U.S., state and foreign deferred tax assets. We
recognized an income tax benefit of $0.9 million related to the acquisition

of
acquired technology.

Results of Operations

Comparison of the years ended December 31, 2020 and 2019

Revenue

The following table presents the revenue of each of our revenue streams, as well as the percentage of total revenue and change from the prior year.






                                            For the Years Ended December 31,
                                             2020                        2019                 Change in Revenues

(Dollars in thousands)              Revenue     % of Total      Revenue    

% of Total            $            %
Product Revenue                     $ 13,718            83 %    $ 22,758            86 %     $    (9,040)     (40) %
Service Revenue                        2,752            17 %       3,681            14 %            (929)     (25) %
Total Revenue                       $ 16,470           100 %    $ 26,439           100 %     $    (9,969)     (38) %




Total revenue for the years ended years ended December 31, 2020 and 2019 was
$16.5 million and $26.4 million, respectively, a decrease of $9.9 million, or
38%. The decrease in total revenue was attributable to a decrease in revenue
from both products and services.

We sold fewer products during the year ended December 31, 2020 as compared to
the year ended December 31, 2019, leading to an approximately 40% decrease in
product revenue. This was primarily due to decreased customer demand and longer
sales cycles resulting from the COVID-19 pandemic. Additionally, as a result of
customer facilities closures associated with the COVID-19 pandemic, we
experienced delays in shipments and installation as well as decreased
utilization of our installed products, leading to a decrease in sales of
consumable materials.

Service revenue decreased during the year ended December 31, 2020, as compared
to the year ended December 31, 2019, primarily due to a decrease in support and
installation revenue from decreased shipments during the period.

The following table presents revenue by geographic region, as well as the percentage of total revenue and change from the prior period.






                                            For the Years Ended December 31,
                                             2020                        2019                 Change in Revenues

(Dollars in thousands)              Revenue     % of Total      Revenue     % of Total           $             %
Americas                            $  6,665            40 %    $ 15,801            60 %    $    (9,136)      (58) %
EMEA (Europe, the Middle East and
Africa)                                7,788            47 %       8,993            34 %         (1,205)      (13) %
APAC (Asia­Pacific)                    2,017            12 %       1,645  

          6 %             372        23 %
Total Revenue                       $ 16,470           100 %    $ 26,439           100 %    $    (9,969)      (38) %



Total revenue decreased due to fewer product sales in the Americas and EMEA regions driven by decreased customer demand resulting from the COVID-19 pandemic. This decrease was partially offset by increased sales in the APAC region, driven primarily by an improvement in hardware product volume sold in the region during the year ended December 31, 2020.



                                       49

  Table of Contents

Cost of Sales

Total cost of sales during the years ended years ended December 31, 2020 and
2019 was $31.5 million and $50.8 million, respectively, a decrease of
$19.3 million or 38%. The decrease in total cost of sales was driven primarily
by a decrease in product cost of sales, which resulted from fewer product sales.
This decrease was partially offset by an increase to our inventory reserves.
During 2020, we recognized a $2.9 million obsolescence inventory charge related
to product redesigns implemented to reduce costs and enhance performance and
functionality.

Gross Loss and Gross Margin

The following table presents gross loss by revenue stream, as well as change in gross loss dollars from the prior period.






                                 For the
                               Years Ended
                              December 31,           Change in Gross
                            2020          2019             Loss

(Dollars in thousands)          Gross Loss               $          %
Products                 $ (13,227)    $ (22,510)   $      9,283    41 %
Services                    (1,822)       (1,847)             25     1 %
Total                    $ (15,049)    $ (24,357)   $      9,308    38 %




Total gross loss during the years ended December 31, 2020 and 2019 was $15.0
million and $24.4 million, respectively. The decrease in gross loss of
$9.3 million is driven by the fact that we sold less units during the year ended
December 31, 2020, as compared to the year ended December 31, 2019. Negative
gross profit during these periods was the result of higher system costs than
selling price, primarily driven by a combination of small purchase quantities
for systems and consumables from our third-party contract manufacturers,
resulting in higher costs, and the selection of suppliers influenced by
time-to-market considerations instead of just cost considerations.

The following table presents gross margin by revenue stream, as well as the change in gross margin from the prior period.






                          For the Years
                              Ended          Change in Gross
                          December 31,            Margin
                          2020      2019    Percentage

(Dollars in thousands)    Gross Margin        Points      %
Products                   (96) %   (99) %        0.03      3 %
Services                   (66) %   (50) %      (0.16)   (32) %
Total                      (91) %   (92) %        0.01      1 %




Total gross margin for the years ended December 31, 2020, and 2019 was (91)% and
(92)%, respectively. The increase in total gross margin was primarily due to the
increase in gross margin from our product revenue, which resulted from a lower
product cost for units shipped in 2020 as compared to 2019. This was partially
offset by an obsolescence inventory charge related to product redesigns
implemented to reduce costs and enhance performance and functionality.

Research and Development


Research and development expenses during the years ended December 31, 2020 and
2019 were $43.1 million and $54.7 million, respectively, a decrease of
$11.6 million, or 21%. The decrease in research and development expenses was
primarily due to a $5.0 million decrease in prototyping costs related to the
maturation of our product development efforts. Additionally, during the year
ended December 31, 2020, we reduced engineering consulting expenses and
headcount to mitigate the impacts and uncertainties around COVID-19 as described
in the "Recent Developments" section above, resulting in savings of $3.9 million
$3.2 million, respectively. These expense reductions were partially offset by
common stock warrant expense associated with product development of $1.7
million.

                                       50

  Table of Contents

Sales and Marketing

Sales and marketing expenses during the years ended years ended
December 31, 2020 and 2019 were $13.1 million and $18.8 million, respectively, a
decrease of $5.7 million, or 30%. The decrease in sales and marketing expenses
was primarily due to a reduction tradeshow and related travel expenses and
marketing headcount during the year ended December 31, 2020 to mitigate the
impacts of, and uncertainties around, the COVID-19 pandemic as described in the
"Recent Developments" section above, resulting in savings of $2.0 million and
$0.9 million, respectively. During the year ended December 31, 2020, there was a
decrease in third party commissions of $1.0 million resulting from our shift
towards a reseller model for our distribution network, as compared to the prior
sales agent model.

General and Administrative

General and administrative expenses during the years ended December 31, 2020 and
2019 were $20.7 million and $11.3 million, respectively, an increase of
$9.4 million, or 83%. The increase in general and administrative expenses was
primarily due to an increase of $5.4 million of professional fees incurred as a
result of the Business Combination and costs related to operating as a public
company, $2.5 million increase in compensation costs related to the modification
of certain equity based awards and $0.6 increase in compensation costs, related
to hiring to support public company requirements.

Interest Expense



Interest expense during the years ended December 31, 2020 and 2019 was
$0.3 million and $0.5 million, respectively, a decrease of $0.2 million, or 40%.
The decrease resulted from a decrease in the variable interest rate paid on our
term loan.

Interest and Other Income, Net


Interest and other income, net during the years ended December 31, 2020 and 2019
and was $1.0 million and $6.0 million, respectively, a decrease of $5.0 million,
or 83%. Interest income decreased primarily due to a decrease in cash available
for investment.

Income Taxes

We recorded an income tax benefit during the year ended December 31, 2020
compared to no provision for the year ended December 31, 2019. The increase was
due to the acquisition of acquired technology treated as a stock acquisition for
tax purposes and an asset acquisition in accordance with GAAP.

We have provided a valuation allowance for all of our deferred tax assets as a
result of our historical net losses in the jurisdictions in which we operate. We
continue to assess our future taxable income by jurisdiction based on our recent
historical operating results, the expected timing of reversal of temporary
differences, various tax planning strategies that we may be able to enact in
future periods, the impact of potential operating changes on our business and
our forecast results from operations in future periods based on available
information at the end of each reporting period. To the extent that we are able
to reach the conclusion that deferred tax assets are realizable based on any
combination of the above factors in a single, or multiple, taxing jurisdictions,
a reversal of the related portion of our existing valuation allowances may
occur.

Non-GAAP Financial Information



In addition to our results determined in accordance with GAAP, we believe that
EBITDA and Adjusted EBITDA, each non-GAAP financial measures, are useful in
evaluating our operational performance. We use this non-GAAP financial
information to evaluate our ongoing operations and for internal planning and
forecasting purposes. We believe that this non-GAAP financial information, when
taken collectively, may be helpful to investors in assessing our operating
performance.

We define "EBITDA" as net loss plus net interest income, provision for income taxes, depreciation and amortization expense.

We define "Adjusted EBITDA" as EBITDA adjusted for stock-based compensation and warrants.



                                       51

  Table of Contents

We believe that the use of EBITDA and Adjusted EBITDA provides an additional
tool for investors to use in evaluating ongoing operating results and trends
because it eliminates the effect of financing, capital expenditures, and
non-cash expenses such as stock-based compensation and warrants, and provides
investors with a means to compare our financial measures with those of
comparable companies, which may present similar non-GAAP financial measures to
investors. However, you should be aware that when evaluating EBITDA and Adjusted
EBITDA we may incur future expenses similar to those excluded when calculating
these measures. In addition, our presentation of these measures should not be
construed as an inference that our future results will be unaffected by unusual
or non-recurring items. Our computation of these measures, especially Adjusted
EBITDA, may not be comparable to other similarly titled measures computed by
other companies because not all companies calculate these measures in the same
fashion.

Because of these limitations, EBITDA and Adjusted EBITDA should not be
considered in isolation or as a substitute for performance measures calculated
in accordance with GAAP. We compensate for these limitations by relying
primarily on our GAAP results and using EBITDA and Adjusted EBITDA on a
supplemental basis. You should review the reconciliation of net loss to EBITDA
and Adjusted EBITDA below and not rely on any single financial measure to
evaluate our business.

The following table reconciles net loss to EBITDA and Adjusted EBITDA during the years ended years ended December 31, 2020 and 2019, respectively:






                                                 For the Years Ended
                                                     December 31,
(Dollars in thousands)                            2020          2019

Net loss attributable to common stockholders $ (90,432) $ (103,596) Interest (income) expense, net

                      (610)        (3,993)
Income tax benefit                                  (940)              -
Depreciation and amortization                       8,589          8,087
EBITDA                                           (83,393)       (99,502)
Stock compensation expense                          8,006          5,215
Warrant expense                                     1,915          1,038
Adjusted EBITDA                                $ (73,472)    $  (93,249)

Liquidity and Capital Resources



We have incurred a net loss in each of our annual periods since our inception.
We incurred net losses of $90.4 million and $103.6 million during the years
ended December 31, 2020 and 2019, respectively. As of December 31, 2020, we had
$595.4 million in cash, cash equivalents, and short-term investments. As noted
in the "Recent Developments" section above, we completed the Business
Combination. We received $534.6 million net cash proceeds as a result of the
transaction which we expect to support our operations and investments in the
near term.

Since inception, we have received cumulative net proceeds from the Business
Combination and the sale of our preferred and common stock of $973.4 million to
fund our operations. As of December 31, 2020, our principal sources of liquidity
were our cash, cash equivalents, and short-term investments of $595.4 million
which are principally invested in money market funds and fixed income
instruments.

In June 2018, we entered into a three-year, $20.0 million term loan, which
provided $10.0 million immediately with the remaining principal balance
available to be drawn in up to three draws of not less than $2.0 million for
12 months from close of the facility. We entered into this loan to fund capital
expenditures associated with our corporate office. Interest is calculated using
the Wall Street Journal Prime rate less 50 basis points, payable monthly in
arrears. If our cash and investments fall below $30.0 million, cash equal to the
total outstanding amount of the debt is required to be placed in a money market
account. In connection with this loan, we are also subject to periodic reporting
requirements, and the lender has a first priority lien on all assets. Repayment
terms include interest only payments for 36 months, with the principal coming
due in June 2021.

In April 2020, we received loan proceeds in the amount of approximately
$5.4 million under the Paycheck Protection Program, or the "PPP"). The PPP,
established as part of the Coronavirus Aid, Relief and Economic Security Act,
provides for loans to qualifying businesses. We repaid the loan in its entirety
on May 13, 2020.

                                       52

  Table of Contents

We believe that our existing capital resources will be sufficient to support our
operating plan and cash commitments for at least the next 12 months. As of
December 31, 2020, we had $483.5 million in cash and cash equivalents, and
$111.9 million in short-term liquid investments. This liquid asset balance
significantly exceeds our current liabilities of $30.5 million as of the same
date. If we anticipate that our actual results will differ from our operating
plan, we believe we have sufficient capabilities to enact cost savings measures
to preserve capital.

We expect net losses to continue in connection with our ongoing activities, particularly as we continue to invest in commercialization and new product development. Additionally, we may engage in future acquisitions which may require additional capital.

Cash Flows



Since inception, we have primarily used proceeds from the Business Combination,
issuances of preferred stock and debt instruments to fund our operations. The
following table sets forth a summary of cash flows for the periods presented:




                                                               For the Years Ended
                                                                  December 31,
(Dollars in thousands)                                          2020          2019

Net cash used in operating activities                        $ (80,575)    $ (97,202)
Net cash used in investing activities                          (36,983)    

(26,032)


Net cash provided by financing activities                       534,922    

160,352

Net change in cash, cash equivalents, and restricted cash $ 417,364 $ 37,118

Cash Flows for the years ended December 31, 2020 and 2019

Operating Activities


Net cash used in operating activities was $80.6 million for the year ended
December 31, 2020, primarily consisting of $90.4 million of net losses, adjusted
for non-cash items, which primarily included depreciation and amortization
expense of $8.5 million, stock-based compensation expense of $8.0 million, and
warrant expense of $1.9 million, as well as a $7.9 million increase in cash
consumed by working capital. The increase in cash consumed by working capital
was primarily driven by an increase in certain assets including accounts
receivable and inventory alongside a decrease in certain liabilities including
accounts payable. This increase in cash consumed by working capital was
partially offset by an increase in certain liabilities including accrued
expenses and other current liabilities and customer deposits.

Net cash used in operating activities was $97.2 million for the year ended
December 31, 2019, primarily consisting of $103.6 million of net losses,
adjusted for certain non-cash items, which primarily included depreciation and
amortization expense of $8.1 million and stock-based compensation expense of
$5.2 million, as well as a $5.3 million increase in cash consumed by working
capital. The increase in cash consumed by working capital was primarily driven
by an increase in certain assets including accounts receivable and inventory
alongside a decrease in certain liabilities including accounts payable and
deferred revenue. This increase in cash consumed by working capital was
partially offset by an increase in certain liabilities including accrued
expenses and other current liabilities.

The majority of our inventory consists of finished goods. Inventory balances may
fluctuate during cycles of new product launch, commercialization and planned
growth of production and sales of products.

Investing Activities



Net cash used in investing activities was $37 million for the year ended
December 31, 2020, primarily consisting of purchases of marketable securities of
$136.3 million, offset by proceeds from sales and maturities of marketable
securities of $109.0 million. We also paid cash to acquire two companies, made
an investment in a privately held company in the form of convertible debt in the
amount of $3.0 million, and purchased $1.4 million of property and equipment.

                                       53

  Table of Contents

Net cash used in investing activities was $26.0 million for the year ended
December 31, 2019, primarily consisting of purchases of marketable securities of
$215.6 million, offset by proceeds from sales and maturities of marketable
securities of $196.8 million, as well as purchases of property and equipment for
$6.9 million.

Financing Activities

Net cash provided by financing activities was $534.9 million for the year ended December 31, 2020, consisting primarily of proceeds from the Business Combination and PIPE financing.

Net cash provided by financing activities was $160.4 million for the year ended December 31, 2019, consisting primarily of proceeds from the issuance of preferred stock.

Off-Balance Sheet Arrangements



We have no off-balance sheet arrangements and do not utilize any "structured
debt," "special purpose" or similar unconsolidated entities for liquidity or
financing purposes.

Critical Accounting Policies and Significant Estimates



Our discussion and analysis of financial condition and results of operations are
based upon our consolidated financial statements, which have been prepared in
accordance with accounting principles generally accepted in the United States.
Certain of our accounting policies require the application of judgment in
selecting the appropriate assumptions for calculating financial estimates. By
their nature, these judgments are subject to an inherent degree of uncertainty.
We periodically evaluate the judgments and estimates used for our critical
accounting policies to ensure that such judgments and estimates are reasonable
for our interim and year-end reporting requirements. These judgments and
estimates are based on our historical experience (where available), current
trends and information available from other sources, as appropriate. If
different conditions result from those assumptions used in our judgments, the
results could be materially different from our estimates. We believe the
following critical accounting policy requires significant judgments and
estimates in the preparation of our consolidated financial statements:

Revenue Recognition


We recognize revenue from sale of products upon transfer of control, which is
generally at the point of shipment. Revenue from sale of services may be
recognized over the life of the associated service contract or as services are
performed, depending on the nature of the services being provided.

Our contracts with customers often include promises to transfer multiple
products and services to the customer. Judgment is required to determine the
separate performance obligations present in a given contract, which we have
concluded are generally capable of being distinct and accounted for as separate
performance obligations. We use standalone selling price, or SSP, to allocate
revenue to each performance obligation. Significant judgment is required to
determine the SSP for each distinct performance obligation in a contract.

We began generating revenue in the fourth quarter of 2018, and as such, we have
had limited standalone sales of our products and services. The absence of
observable prices resulting from our relatively short period of revenue
generation requires us to estimate the SSPs of distinct performance obligations
in a given contract.

We determine SSP using market conditions and other observable inputs. We
typically have more than one SSP for individual products and services due to the
stratification of our customers. The SSP generally varies by size of the
customer. Our determination of SSP may change in the future as standalone sales
of products and services occur, providing observable prices.

Stock-Based Compensation



We have applied the fair value recognition provisions of Financial Accounting
Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic
718 Compensation-Stock Compensation to account for the stock-based compensation
for employees and non-employees. We recognize compensation costs related to
stock options granted to employees and non-employees based on

                                       54

Table of Contents

estimated fair value of the award on the date of grant. Described below is the methodology we have utilized in measuring stock-based compensation expense.


Determining the amount of stock-based compensation to be recorded requires us to
develop estimates of the fair value of stock-based awards as of their
measurement date. We recognize stock-based compensation expense over the
requisite service period, which is the vesting period of the award. Calculating
the fair value of stock-based awards requires that we make highly subjective
assumptions. We use the Black-Scholes option pricing model to value our stock
option awards. Use of this valuation methodology requires that we make
assumptions as to the volatility of our common stock, the fair value of our
common stock on the measurement date, the expected term of our stock options,
the risk-free interest rate for a period that approximates the expected term of
our stock options and our expected dividend yield. Because we have a limited
operating history, we utilize data from a representative group of publicly
traded companies to estimate the expected stock price volatility. We selected
representative companies from the additive manufacturing industry with
characteristics similar to us. We use the simplified method as prescribed by the
SEC Staff Accounting Bulletin No. 107, Share-Based Payment as we do not have
sufficient historical stock option activity data to provide a reasonable basis
upon which to estimate the expected term of stock options granted to employees
and non-employees. For our August 5, 2020 grants we were precluded from using
the simplified method, therefore expected term for this grant was based on
forecasted exercises. We utilize a dividend yield of zero based on the fact that
we have never paid and are not expected to pay cash dividends. The risk-free
interest rate used for each grant is an interpolated rate to match the term
assumption based on the U.S. Treasury yield curve as of the valuation date.



The following table presents the dates of stock options that we granted or
modified from the earliest presented period in these financial statements
through December 31, 2020 with the corresponding exercise price for each option
grant or modifications and our current estimate of the fair value per option on
each grant or modification date, which we utilize to calculate stock-based
compensation expense.


                                                                           Weighted-Average
                       Number of                        Estimated Fair      Estimated Fair
                      Share Options Exercise Price      Value per Share     Value per Share
Grant Date               Granted       per Share        of Common Stock       of Options
March 1, 2019             1,555,218  $          3.34 $             3.34 $               1.76
May 8, 2019               1,137,463  $          3.34 $             3.34 $               1.75
September 18, 2019          723,103  $          3.34 $             3.34 $               1.70
November 13, 2019           701,957  $          3.34 $             3.34 $               1.71
March 12, 2020              473,625  $          3.34 $             3.34 $               1.65
June 11, 2020             4,176,283  $          1.40 $             1.40 $               0.70
July 14, 2020             3,087,308  $          1.40 $             7.98 $               6.87
August 5, 2020              713,803  $          1.40 $             7.98 $               6.78



Determination of the fair value of Common Stock on Grant Dates


Prior to the Business Combination on December 9, 2020, there was no public
market for our equity instruments to date, as a result, the estimated fair value
of our common stock has historically been determined by our board of directors
as of the grant date with input from management, considering our most recently
available third-party valuations of common stock and our board of directors'
assessment of additional objective and subjective factors that the board
believed were relevant and which may have changed from the date of the most
recent valuation through the date of grant. We engaged an independent
third-party valuation specialist to perform contemporaneous valuations of our
common stock in connection with each of our convertible preferred stock
issuances and as of June 30, 2019, December 31, 2019, March 31, 2020, and
August 20, 2020. The valuations were performed in accordance with the guidance
outlined in the American Institute of Certified Public Accountants, or AICPA,
Practice Aid, Valuation of Privately-Held Company Equity Securities Issued as
Compensation. The independent third-party valuation specialist considered all
objective and subjective factors that it believed to be relevant for each
valuation conducted in accordance with AICPA's Practice Aid, including our best
estimate of our business condition, prospects, and operating performance at each
valuation date. Other significant factors included:



? The rights and preferences of our preferred stock as compared to those of our

common stock, including liquidation preferences of preferred stock;






                                       55

  Table of Contents

? Our results of operations and financial position;

? Our stage of development and business strategy and the material risks related

to our business and industry;

? The composition of, and changes to, our management team and board of directors;

? The lack of liquidity of our common stock;

? The valuation of publicly traded peer companies; and

? The likelihood of achieving a liquidity event for the holders of our common


   stock and stock options, given prevailing market conditions




The dates of the contemporaneous valuations have not always coincided with the
date of our stock option grants. In determining the exercise price of the stock
options set forth in the table above, our board of directors considered, among
other things, the most recent contemporaneous valuation of our common stock and
their assessment of additional objective and subjective factors that were
relevant as of the grant dates. These factors include the current operating
performance of the Company, assumptions regarding the future operating
performance of the Company, and the likelihood of achieving a liquidity event in
the capital markets. If we had made different assumptions, our stock-based
compensation expense, net loss, and net loss per share applicable to common
stockholders could have been materially different.



Following the Business Combination, the fair value of the entity's common stock is determined based on the quoted market price of the entity's common stock.

Recent Accounting Pronouncements

Information regarding recent accounting pronouncements is included in "Note 2. Summary of Significant Accounting Policies" to our consolidated financial statements in this Annual Report on Form 10-K.

© Edgar Online, source Glimpses